Moshe Oren

Molecular Biology · 2000–2020

A researcher in the Science corpus: 12 papers; trusts 20 researchers and is trusted by 11 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 350 citations into it; #4,279 of 17,773 by trust here, #2,699 by citations
• Immunology — 126 citations into it
• Oncology — 126 citations into it; #225 of 1,698 by trust here, #479 by citations
• Cancer Research — 101 citations into it; #1,768 of 1,780 by trust here, #703 by citations
• Physiology — 54 citations into it
• Biotechnology — 25 citations into it; #50 of 496 by trust here, #59 by citations

Whom Moshe Oren trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Paul Polakis
2. Arnold J. Levine
3. C. Sherr
4. Angelina V. Vaseva
5. J. Massagué
6. Varda Rotter
7. R. Brosh
8. Benjamin P. Lewis
9. T. Soussi
10. Karen H. Vousden

Who trusts Moshe Oren overall

1. William A. Freed-Pastor
2. R. Brosh
3. Arnold J. Levine
4. J. Campisi
5. Julian Downward
6. H. Hermeking
7. Varda Rotter
8. B. Reva
9. Magali Olivier

Papers from Moshe Oren's perspective

Ordered by how strongly the researchers Moshe Oren trusts endorse each paper. Same corpus, a different order for every researcher.

1. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. (Cell)
2. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. (Cell)
3. Stem cells, cancer, and cancer stem cells (Nature)
4. p53 and human cancer: the first ten thousand mutations. (Advances in Cancer Research)
5. When mutants gain new powers: news from the mutant p53 field (Nature Reviews. Cancer)
6. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.
7. The UCSC Genome Browser Database (Nucleic Acids Res.)
8. Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound (Nature Medicine)
9. Mutant p53 gain-of-function in cancer. (Cold Spring Harbor Perspectives in Biology)
10. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. (Cancer Research)

Their papers

• Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. (2007) — 1,412 citations
• Mutant p53 gain-of-function in cancer. (2010) — 781 citations
• Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 (2018) — 5,732 citations
• The first 30 years of p53: growing ever more complex (2009) — 1,883 citations
• Global and Local Architecture of the Mammalian microRNA–Transcription Factor Regulatory Network (2007) — 520 citations
• Physical Interaction with Yes-associated Protein Enhances p73 Transcriptional Activity* (2001) — 247 citations
• The p53-Mdm2 module and the ubiquitin system. (2003) — 814 citations
• Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. (2000) — 624 citations
• Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers (2020) — 1,059 citations
• Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. (2011) — 1,021 citations
• Decision making by p53: life, death and cancer (2003) — 1,139 citations
• ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. (2001) — 796 citations